Search for other papers by Xian Qiu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Department of Nuclear Medicine, The First Hospital of Jilin University, Changchun, China
Search for other papers by Ri Sa in
Google Scholar
PubMed
Department of Nuclear Medicine & Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China
Search for other papers by Hao Fu in
Google Scholar
PubMed
Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
). However, data on salvage therapy using apatinib in this entity are lacking, hampering sufficient exhibition of its efficacy and safety profile in the treatment of RR-DTC. Therefore, we conceived this open-label study based on real-world evidence to
Search for other papers by Bruno Bouça in
Google Scholar
PubMed
Search for other papers by Ana Cláudia Martins in
Google Scholar
PubMed
Search for other papers by Paula Bogalho in
Google Scholar
PubMed
Search for other papers by Lídia Sousa in
Google Scholar
PubMed
Search for other papers by Tiago Bilhim in
Google Scholar
PubMed
Search for other papers by Filipe Veloso Gomes in
Google Scholar
PubMed
Search for other papers by Élia Coimbra in
Google Scholar
PubMed
Search for other papers by Ana Agapito in
Google Scholar
PubMed
Search for other papers by José Silva-Nunes in
Google Scholar
PubMed
, thus, a major cause of morbidity and mortality. Amiodarone is widely considered to be the most effective antiarrhythmic drug, even for the CHD population. Treatment with this class III anti-arrhythmic drug is commonly used in these patients as it is
Search for other papers by Zhen Gao in
Google Scholar
PubMed
Search for other papers by Hongtao Zhang in
Google Scholar
PubMed
Search for other papers by Lijuan Zhang in
Google Scholar
PubMed
Search for other papers by Huimin Yu in
Google Scholar
PubMed
Search for other papers by Xuemin Di in
Google Scholar
PubMed
Search for other papers by Zeyang Wang in
Google Scholar
PubMed
Search for other papers by Zezhou Liu in
Google Scholar
PubMed
Search for other papers by Aixia Sui in
Google Scholar
PubMed
Search for other papers by Juan Wang in
Google Scholar
PubMed
Search for other papers by Gaofeng Shi in
Google Scholar
PubMed
]. Furthermore, individualized treatment strategies have been recommended in patients with disease recurrence limited to a local site [ 4 ]. In this case report, we describe a valuable salvage technique using image-guided 125 I seed brachytherapy to treat
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Fausto Bogazzi in
Google Scholar
PubMed
Search for other papers by Luca Chiovato in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Thera P. Links in
Google Scholar
PubMed
Search for other papers by Mark Vanderpump in
Google Scholar
PubMed
periods of treatment. If AIT presents an emergency (see paragraph above), salvage thyroidectomy can be considered in AIT 2, as well as in AIT 1 and mixed/indefinite forms (Fig. 2 ). Recommendation 6 . We recommend oral glucocorticoids as the first
Search for other papers by Samuel Chan in
Google Scholar
PubMed
Search for other papers by Katarina Karamali in
Google Scholar
PubMed
Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed
Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed
Search for other papers by John Watkinson in
Google Scholar
PubMed
Search for other papers by Vinidh Paleri in
Google Scholar
PubMed
Search for other papers by Iain Nixon in
Google Scholar
PubMed
Search for other papers by Dae Kim in
Google Scholar
PubMed
WDTC.” Ease of salvage treatment is dependent on the site of recurrence, with patients presenting with multiple surgeries or distant metastases demonstrating significantly worse overall or disease-specific survival, or disease control [ 29 - 32 ]. In
Search for other papers by Clotilde Saïe in
Google Scholar
PubMed
Search for other papers by Cécile Ghander in
Google Scholar
PubMed
Search for other papers by Samir Saheb in
Google Scholar
PubMed
Search for other papers by Christel Jublanc in
Google Scholar
PubMed
Search for other papers by Denis Lemesle in
Google Scholar
PubMed
Search for other papers by Charlotte Lussey-Lepoutre in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Fabrice Menegaux in
Google Scholar
PubMed
Search for other papers by Christophe Tresallet in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
of TPE in refractory hyperthyroidism, the conditions under which the sessions were carried out, and to analyze the potential complications of this treatment. We also focused on the outcome of patients after the TPE sessions. In the case of salvage
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy
Search for other papers by Laura Fugazzola in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
5–10% of cases (6–7 new cases/year/million) will develop metastatic disease, mostly located in lungs and bones. The prognosis of these metastatic cases remains favourable as long as they maintain a response to the treatment with radioiodine
Search for other papers by Annamaria Erdei in
Google Scholar
PubMed
Search for other papers by Annamaria Gazdag in
Google Scholar
PubMed
Search for other papers by Bernadett Ujhelyi in
Google Scholar
PubMed
Search for other papers by Edit B Nagy in
Google Scholar
PubMed
Search for other papers by Ervin Berenyi in
Google Scholar
PubMed
Search for other papers by Eszter Berta in
Google Scholar
PubMed
Search for other papers by Zita Steiber in
Google Scholar
PubMed
Search for other papers by Sandor Barna in
Google Scholar
PubMed
Search for other papers by Emese Mezosi in
Google Scholar
PubMed
Search for other papers by Miklos Bodor in
Google Scholar
PubMed
Search for other papers by Endre V Nagy in
Google Scholar
PubMed
: Starting the treatment with diuretics alone resulted in immediate improvement of visual acuity. As evidenced by MRI, the mechanism is a decrease in the water content of orbital tissues. These findings suggest that the addition of diuretics to the standard
Search for other papers by Noriyoshi Takahashi in
Google Scholar
PubMed
Search for other papers by Haruo Matsushita in
Google Scholar
PubMed
Search for other papers by Rei Umezawa in
Google Scholar
PubMed
Search for other papers by Takaya Yamamoto in
Google Scholar
PubMed
Search for other papers by Yojiro Ishikawa in
Google Scholar
PubMed
Search for other papers by Yu Katagiri in
Google Scholar
PubMed
Search for other papers by Shun Tasaka in
Google Scholar
PubMed
Search for other papers by Kazuya Takeda in
Google Scholar
PubMed
Search for other papers by Katsuya Fukui in
Google Scholar
PubMed
Search for other papers by Noriyuki Kadoya in
Google Scholar
PubMed
Search for other papers by Kengo Ito in
Google Scholar
PubMed
Search for other papers by Keiichi Jingu in
Google Scholar
PubMed
treated ATC patients with 50 Gy in 10 fractions 3 times a week. The aim of this study was to determine the treatment results and side effects of hypofractionated radiotherapy for ATC. Patients and Methods Patients We retrospectively reviewed a
Department of Medicine I, Johannes Gutenberg University Medical Center, Mainz, Germany
Search for other papers by Alan Chun Hong Lee in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
treatment modalities of Graves’ hyperthyroidism (GH). Systemic glucocorticoids (GCs) were commonly employed in active GO since the 1950s. Over the past decade, we have witnessed the emergence of novel therapeutics which better target the immunological